Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records β€” linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review claims


     Quick Explanation



    Shirin De Viragh β€” scientific strength (evidence-based, cautious)
    Based on currently provided publication/citation metadata, De Viragh appears to have an early-stage research output with one identifiable work and limited citation history. The most directly evidenced contribution here is a study on using large language models to classify research study types for systematic reviews ().
    Bottom line: promising methodological direction, but insufficient public track record (from provided data) to judge robustness, reproducibility, and downstream adoption.



     Long Explanation



    Author Review: Shirin De Viragh

    Epistemic posture: I only evaluate what is explicitly supported by the information you provided plus the single explicitly identifiable work (with DOI). Where the record is thin, I downgrade confidence.

    1) Evidence available (from provided metadata)

    • Public works identified here: 1
    • Citation history (as provided): cited-by count is small; h-index is reported as 0 or 1 depending on which OpenAlex match you provided.
    • Most specific work we can anchor: StudyTypeTellerβ€”Large language models to automatically classify research study types for systematic reviews (preprint; DOI given).

    2) Publication & citation profile (visualized from provided counts)

    The following plots use the counts_by_year values you provided (single year: 2025).

    3) Core scientific claim we can directly ground: StudyTypeTeller

    The provided DOI anchors a preprint titled StudyTypeTellerβ€”Large language models to automatically classify research study types for systematic reviews.

    3.1 What the work is (scientific task)

    • Problem class: automated study-type classification to support systematic reviews (a meta-research / evidence-synthesis enabling task).
    • Why it matters: classification quality affects inclusion/exclusion decisions and downstream effect estimates in reviews. (General methodological relevance; anchored to the study’s purpose.)

    3.2 Scientific strength (what I can and cannot evaluate from provided info)

    • Strength (supported): The author’s evidenced work lies in a technically demanding directionβ€”automating parts of evidence synthesis via large language modelsβ€”where evaluation must be careful to avoid label leakage, dataset bias, and annotation drift.
    • What I cannot verify here: model architecture details, dataset composition, labeling guidelines, train/test splits, error analysis by study-type, calibration, robustness to publication style, and whether results were independently reproducibleβ€”because those details are not included in your provided excerpt.
    • Key skepticism points (biologically relevant even though this is ML/meta-research):
      • Label validity: β€œstudy type” taxonomies are sometimes inconsistent across review domains; if the labeling standard is narrow, performance may not transfer.
      • Distribution shift: LLM-based classifiers can behave differently across journals and time windows; without explicit robustness testing, generalization is uncertain.
      • Selection bias & framing bias: if training data under-represents certain study types (or mislabels borderline cases), metrics can look strong while failing in edge categories that matter for reviews.

    4) Scientific citation metrics (from your provided author metadata)

    Your provided data indicates very limited citation footprint: one work and cited-by counts around 0–4 depending on the OpenAlex match, with h-index reported as 0–1.
    (No DOI-backed evidence exists for these bibliometric numbers within the allowed citation format; they are treated as provided metadata only.)

    Interpretation (critical)

    • Short time horizon: if the preprint is recent, citation counts are expectedly low (so low citations do not necessarily imply low quality).
    • But: with only one identified work here, I cannot assess whether the author has a broader pattern of methodological rigor, transparent reporting, or independent follow-up contributions.

    5) Scores (derived from evidence density + scientific scrutiny)

    Dimension Score (1–10) What drives it (no citations)
    Scientific quality 3 Only one anchored preprint; can’t verify rigorous evaluation details from provided text.
    Scientific rigor 3 Rigor hinges on dataset construction, labeling, splits, and error analysisβ€”unavailable here.
    Novelty 4 Meta-research automation can be incremental; novelty can’t be judged without method specifics.
    Communication 4 No author prose provided here to evaluate; score reflects typical preprint clarity uncertainty.

    6) What would most disprove/upgrade this assessment?

    • For rigor: transparent reporting of labeling guidelines, train/test splits, external validation, calibration, and failure-mode analysis for ambiguous study types (if present in the full preprint).
    • For real-world impact: adoption or benchmarking by independent groups showing the classifier improves systematic review screening quality.
    • For reliability: reproducibility checks using alternative datasets or different domains/journals showing consistent performance.

    7) Practical next steps (BGPT-friendly queries)



    Feedback:    

    Updated: March 27, 2026

     BGPT Author Review



    Scientific Quality

    30%

    Only one explicitly evidenced work (a 2025 preprint) with limited citation footprint in the provided metadata. I cannot assess key scientific rigor elements (data curation, labeling validity, split strategy, external validation, calibration, and error modes) from the provided excerpt, so confidence is low. Likely promising direction, but current evidence density is too small for a high score.



    Communication Quality

    40%

    No author-written text is provided here to evaluate clarity directly. The score reflects uncertainty: preprints vary widely in accessibility and methodological transparency.



    Author Novelty

    40%

    Automating study-type classification for systematic reviews is a plausible innovation area, but novelty cannot be judged without method specifics, comparisons, and demonstrated advantages beyond prior work.



    Scientific Rigor

    30%

    Rigorous assessment requires details of labeling standards, dataset construction, evaluation design, and reproducibility. Those critical elements are not included in the provided information, so rigor is scored conservatively.

     Analysis Wizard



    It extracts the provided study’s structured claims from the DOI-linked preprint PDF, then summarizes evaluation datasets/splits and plots reported metrics to expose which error modes are most consequential.



     Hypothesis Graveyard



    That overall held-out accuracy alone is sufficient to guarantee review-safe screeningβ€”unlikely because downstream decisions depend on error distribution across study-type boundaries.


    That performance on one dataset implies generalization across systematic-review domainsβ€”unlikely without explicit external validation and calibration checks.

     Science Art


    Author Review: Shirin De Viragh Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT